Fukumura M, Cappon G D, Pu C, Broening H W, Vorhees C V
Division of Developmental Biology, Children's Hospital Research Foundation, 3333 Burnet Avenue, Cincinnati, OH 45229, USA.
Brain Res. 1998 Sep 21;806(1):1-7. doi: 10.1016/s0006-8993(98)00656-8.
The neurotoxic effects of a single administration of methamphetamine (MA) were studied under conditions conducive to MA-induced hyperthermia. After a single dose of MA (10, 20, 30, or 40 mg/kg, s. c.) or saline (3 ml/kg) to Sprague-Dawley CD rats, rectal temperatures were monitored for 9 h in a room with an ambient temperature of 22.0+/-0.5 degrees C. MA induced significant dose-dependent hyperthermia, however, no significant increase in mortality occurred. Neostriatal DA, 5-HT, TH, and GFAP were assayed 3 days following treatment. MA induced dose-dependent reductions of DA, 5-HT and TH, and increased GFAP. For DA, at doses of 20, 30, or 40 mg/kg the reductions were to 71%, 49%, and 29%, and for 5-HT were to 73%, 44%, and 19% of control values. No reductions were seen after the 10 mg/kg dose. Semiquantitative analysis Western blots of TH and GFAP demonstrated that TH was reduced to 52%, 75%, and 28%, and GFAP was increased to 125%, 134%, and 149% of control values at MA doses of 20, 30, or 40 mg/kg, respectively. No significant changes in TH or GFAP were seen at the 10 mg/kg MA dose. These results demonstrate that a single-dose of MA can be as effective as the widely used four-dose every 2 h regimen. Moreover, mortality can be minimized by monitoring core body temperature and preventing MA-induced hyperthermia from exceeding 41.5 degrees C.
在有利于甲基苯丙胺(MA)诱导体温过高的条件下,研究了单次给予MA的神经毒性作用。给Sprague-Dawley CD大鼠单次注射MA(10、20、30或40 mg/kg,皮下注射)或生理盐水(3 ml/kg)后,在环境温度为22.0±0.5℃的房间内监测直肠温度9小时。MA诱导了显著的剂量依赖性体温过高,然而,死亡率没有显著增加。在治疗3天后测定新纹状体中的多巴胺(DA)、5-羟色胺(5-HT)、酪氨酸羟化酶(TH)和胶质纤维酸性蛋白(GFAP)。MA诱导了DA、5-HT和TH的剂量依赖性降低,并使GFAP增加。对于DA,在20、30或40 mg/kg剂量下,降低至对照值的71%、49%和29%,对于5-HT分别降低至对照值的73%、44%和19%。在10 mg/kg剂量后未见降低。对TH和GFAP的蛋白质免疫印迹进行半定量分析表明,在MA剂量为20、30或40 mg/kg时,TH分别降低至对照值的52%、75%和28%,GFAP分别增加至对照值的125%、134%和149%。在10 mg/kg MA剂量下,TH或GFAP未见显著变化。这些结果表明,单次剂量的MA可以与广泛使用的每2小时四剂量方案一样有效。此外,通过监测核心体温并防止MA诱导的体温过高超过41.5℃,可以将死亡率降至最低。